Polymerase Variants and Uses Thereof

US2016333327A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016333327-A1
Application numberUS-201615151364-A
CountryUS
Kind codeA1
Filing dateMay 10, 2016
Priority dateMay 14, 2015
Publication dateNov 17, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Described herein is a variant pol6 polymerase having at least one mutation selected from H223, N224, Y225, H227, 1295, Y342, T343, I357, S360, L361, I363, S365, S366, Y367, P368, D417, E475, Y476, F478, K518, H527, T529, M531, N535, G539, P542, N545, Q546, A547, L549, I550, N552, G553, F558, A596, G603, A610, V615, Y622, C623, D624, I628, Y629, R632, N635, M641, A643, I644, T647, I648, T651, I652, K655, W656, D657, V658, H660, F662, L690 and combinations thereof.

First claim

Opening claim text (preview).

What is claimed is: 1 . A modified DNA polymerase having a DNA polymerase activity comprising an amino acid sequence having at least 70% sequence identity to the amino acid sequence as set forth in SEQ ID NO: 1 or 2, which amino acid sequence includes one or more amino acid substitutions selected from the group consisting of H223, N224, Y225, H227, I295, Y342, T343, I357, S360, L361, I363, S365, S366, Y367, P368, D417, E475, Y476, F478, K518, H527, T529, M531, N535, G539, P542, N545, Q546, A547, L549, I550, N552, G553, F558, A596, G603, A610, V615, Y622, C623, D624, I628, Y629, R632, N635, M641, A643, I644, T647, I648, T651, I652, K655, W656, D657, V658, H660, F662, L690, and combinations thereof. 2 . The modified DNA polymerase of claim 1 , wherein the substitutions are selected from the group consisting of H223A, N224Y/L/Q/M/R/K, Y225L/T/I/F/A/M, H227P/E/F/Y, I295 W/F/M/E, Y342L/F, T343N/F, I357G/L/Q/H/W/M/A/E/Y/P, S360G/E/Y, L361M/W/V/F, I363V/A/R/M/W, S365Q/W/M/A/G, S366A/L, Y367L/E/M/P/N/F, P368G, D417P, E475D, Y476V, F478L, K518Q, H527 W/R/L/Y/T/M, T529M/F, M531H/Y/A/K/R/W/T/L/V/G, N535L/Y/M/K/I/R/W/Q, G539Y/F, P542E/S/G, N545K/D/S/L/R/Q/W, Q546 W/F, A547M/Y/W/F/V/S, L549Q/Y/H/G/R/K, I550A/W/T/G/F/S, N552L/M/S/T, G553S/T/E/Q/K/R/M, F558P/T, A596S, G603T/A/L, A610T/E, V615A/T, Y622A/M, C623G/S/Y/F, D624F/K, I628Y/V/F/L/M, Y629 W/H/M/K, R632L/C, N635D, M641L/Y, A643L, I644H/M/Y, T647G/A/E/K/S/Y, I648K/R/V/N/T/L, T651Y/F/M, I652Q/G/S/N/F/T/A/L/E/K/M, K655G/F/E/N/Q/M/A, W656E, D657R/P/A/E, V658L, H660A/Y, F662I/L, L690M and combinations thereof. 3 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has an altered characteristic as compared to the parental polymerase. 4 . The modified DNA polymerase of claim 3 , wherein the altered characteristic is selected from fidelity, processivity, elongation rate, stability, solubility and the ability to bind and/or incorporate polyphosphate nucleotides such as a tetraphosphate, pentaphosphate, hexaphosphate, heptaphosphate or octophosphate nucleotide. 5 . The modified DNA polymerase of claim 3 , wherein the altered characteristic is the ability to incorporate a nucleotide polyphosphate having 4, 5, 6, 7 or 8 phosphates into a growing DNA strand. 6 . The modified DNA polymerase of claim 5 , wherein the nucleotide polyphosphate is tagged. 7 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to S366A/L. 8 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to E475D. 9 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to F478L. 10 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to K518Q. 11 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to T529M. 12 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to N535L. 13 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to N545K/L. 14 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to A547F. 15 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to G553S. 16 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to T647G/Y. 17 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to T651Y. 18 . The modified DNA polymerase of claim 1 , wherein said modified polymerase has a substitution corresponding to I652Q/A/L/E/K/M. 19 . The modified DNA polymerase of claim 1 selected from H223A; N224Y/L/Q/M/R/K; Y225L/1/T/F/A/M; H227P/E/F/Y; I295F/E/M/W; Y342L/F; T343N/F; I357G/L/Q/H/W/M/A/E/Y/P; S360G/E/Y; L361M/W/V/F; I363V/A/R/M/W; S365Q/W/M/A/G; S366A/L; Y367L/E/M/P/N/F; P368G; D417P; E475D; Y476V; F478L; K518Q; H527W/R/L/Y/T/M; T529M/F; M531H/Y/A/K/R/W/T/L/V/G; N535L/Y/M/K/I/R/W/Q; P542E/S/G; N545D/K/S/L/R/Q/W; Q546 W/F; A547F/M/W/Y/V/S; L549H/Y/Q/G/R/K; I550A/W; I550T/G/F/S; N552L/M/T; G553S/T/E/Q/K/R/M; F558P/T; A596S; G603T/A/L; A610T/E; V615A/T; Y622A/M; C623G/S/Y/A/F; D624F/K; I628Y/V/F/L/M; Y629 W/H/M/K; R632L/C; N635D; M641 L/Y; A643L; I644H/M/Y; T647G/A/E/K/S/Y; I648K/R/V/N/T/L; T651Y/F/M; I652Q/G/S/N/F/T/A/L/E/K/M; K655G/F/E/N/Q/M/A; W656E; D657R/P/A/E; V658L; H660A/Y; F662I/L; L690M; S366A+N535L; T651Y+N535L; Y342L+E475D+F478L; T343N+D417P+K518Q; N535L+N545K+T651Y; I363V+E475D+Y476V; S366L+G553S+F558P; S366A+N535L+A547M; S366A+P542E+N545K; S366A+P542E+I652Q; S366A+N535L+T529M; S366A+N535L+I652Q; S366A+N535L+N545K; T651 Y+P542E+N545K; T651Y+P542E+Q546 W; T651Y+P542E+S366A; T651 Y+N535L+N545K; S366A+N535I+I652Q; T651Y+S366A+A547F; T647G+A547F+Y225T; A547F+A610T+S366A; A547F+A610T+Y225I; S366A+T647G+A547F; T529M+S366A+A547F; T647E+S366A+A547F; T529M+T647G+A547F; N545K+S366A+A547F; T647G+A547F+T529M; T529M+A610T+A547F; M641 Y+T529M+A547F; T647G+C623G+A547F; A610T+I295 W+T651Y; V615A+M531Y+T647G; S366 L+F478L+A596S+L690M; H223A+G553S+A643 L+F662I; N535L+N545K+T651Y+T529M; N535L+N545K+T651Y+N635D; N535L+N545K+T651 Y+I652Q; S366A+N535L+I652Q+T529M; S366A+S365A+P368G+G603T; N535L+N545K+T651Y+T647G; S366A+N535L+I652Q+A547Y; S366A+N535L+A547M+T647G; T529M+S366A+A547F+N545K; T529M+S366A+A547F+N545R; T529M+S366A+A547F+N552L; T529M+S366A+A547F+Y629 W; N535I+N545K+T651Y+T529M; N535I+N545K+T651 Y+N635D; N535I+N545K+T651 Y+I652Q; N535L+N545K+T651Y+T647G+C623G; N535L+N545K+T651 Y+T647G+I628Y; S366A+N535L+A547M+T647G+S360G; N535I+N545K+T651 Y+I652Q+Y225I; N535L+N545K+T651Y+T647G+K655G; N535L+N545K+T651Y+T647G+L549Q; S366A+N535L+I652Q+A547Y+K655G; T529M+S366A+A547F+N545L+Y629 W; T529M+S366A+A547F+N545L+Y225L; T529M+S366A+A547F+N545L+Y225F; T529M+S366A+A547F+N545L+K655F; T529M+S366A+A547F+N545L+N552L; T529M+S366A+A547F+N545R+M531A; T529M+S366A+A547F+N545R+G539Y; T529M+S366A+A547F+N545R+V658L; T529M+S366A+A547F+N545L+Y225L+D657R; T529M+S366A+A547F+N545L+Y225L+N552L; T529M+S366A+A547F+N545L+Y225L+I652G; T529M+S366A+A547F+N545L+Y225L+I652Q; T529M+S366A+A547F+N545L+Y225L+N552M T529M+S366A+A547F+N545L+Y225L+D657R+N224R; T529M+S366A+A547F+N545L+Y225L+D657R+I628M; T529M+S366A+A547F+N545L+Y225L+D657R+K655A; and T529M+S366A+A547F+N545L+Y225L+D657R+Y629 W. 20 . The modified DNA polymerase of claim 1 comprising S366A+T529M+N545L+A547F. 21 . The modified DNA polymerase of claim 20 further comprising at least one mutation selected from a. Y225L/F/A/M; b. M531A/G; c. G539Y; d. N552L/T; e. Y629 W/K; f. K655F/Q/M/A; and g. D657R/E/P/A. 22 . The modified DNA polymerase of claim 1 comprising S365A+S366A+P368G+G603T. 23 . The modified DNA polymerase of claim 1 , wherein said polymerase comprises less than 10 mutations.

Assignees

Inventors

Classifications

  • DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

  • C12N9/1252Primary

    DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase · CPC title

  • C12N9/1241Primary

    Nucleotidyltransferases (2.7.7) · CPC title

  • Nucleotidyltransferases (2.7.7) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016333327A1 cover?
Described herein is a variant pol6 polymerase having at least one mutation selected from H223, N224, Y225, H227, 1295, Y342, T343, I357, S360, L361, I363, S365, S366, Y367, P368, D417, E475, Y476, F478, K518, H527, T529, M531, N535, G539, P542, N545, Q546, A547, L549, I550, N552, G553, F558, A596, G603, A610, V615, Y622, C623, D624, I628, Y629, R632, N635, M641, A643, I644, T647, I648, T651, I6…
Who is the assignee on this patent?
Genia Tech Inc
What technology area does this patent fall under?
Primary CPC classification C12N9/1252. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Nov 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).